no heparin

PreclinicalSmall molecule

TThe University of Texas Health Science Center at San Antonio

no heparin is one of 4 small molecule programs targeting Catheter. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

CatheterWithdrawn

CatheterPreclinical

Withdrawn

Competition

Competitive Landscape

5 competitors in Catheter

#DrugCompanyPhaseTrials

REGN7508

Regeneron

Phase 2

1 2

REGN9933

Regeneron

Phase 2

1 3

Inhaled Nitric Oxide

LLee's Pharmaceutical Limited

Preclinical

1 4

no heparin

TThe University of Texas Health Science Center at San Antonio

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Catheter1 trial

Heparin Versus no Heparin on Duration of Peripherally Inserted Central Catheter (PICC) Patency in Neonates

Withdrawn·TThe University of Texas Health Science Center at San Antonio·N/A·NCT00879957

Unspecified1 trial

Role of Heparin in Poor Responders Undergoing In Vitro Fertilisation

Completed·NNational and Kapodistrian University of Athens·Phase 2/3·NCT01315093·50 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for no heparin. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — no heparin compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for no heparin. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — The University of Texas Health Science Center at San Antonio company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: TThe University of Texas Health Science Center at San Antonio

no heparin

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Catheter1 trial

Unspecified1 trial

References

Drug Info

Quick Facts

Related News